Upload Avatar (500 x 500)
Qingtao Meng
mengqingtao2018@126.com
English, Chinese, German
Hubei
Wuhan University
Medical School
  • 1994-1999 Bachelor of Clinical Medicine, Wuhan University
  • 2001-2004 Master of Anesthesiology, Wuhan University
  • 2006-2012 PhD in Surgery, Wuhan University
  • Published over 70 academic papers, including 40+ SCI indexed and 4 top zone SCI papers
  • 2008-2012 Attending Physician, Anesthesiology, Renmin Hospital, Wuhan University
  • 2012-2017 Associate Chief Physician, Anesthesiology, Renmin Hospital, Wuhan University
  • 2014-2021 Associate Professor, Anesthesiology, Renmin Hospital, Wuhan University
  • 2017-2020 Chief Physician, Anesthesiology, Renmin Hospital, Wuhan University
  • 2020-present Second-level Chief Physician, Anesthesiology, Renmin Hospital, Wuhan University
  • 2021-present Professor, Anesthesiology, Renmin Hospital, Wuhan University
  • 2014 Second Prize, Hubei Province Science and Technology Progress Award
  • 2020 Second Prize, Hubei Province Science and Technology Achievement Promotion Award
MODS mechanism research and prevention
Perioperative organ protection
  • Feasibility and Safety of Remazolam versus Propofol When Inserting Laryngeal Masks Without Muscle Relaxants During Hysteroscopy, Meng QT*, 2023
  • Basement membrane-related regulators for prediction of prognoses and responses to diverse therapies in hepatocellular carcinoma, Meng QT*, 2023
  • Macrophage Sprouty4 deficiency diminishes sepsis-induced acute lung injury in mice, Meng QT*, 2022
  • CD36 inhibition partially attenuates myocardial injury in diabetic rats with ischemic postconditioning, Meng QT*, 2022
  • Loss of Sam50 in hepatocytes induces cardiolipin-dependent mitochondrial membrane remodeling to trigger mtDNA release and liver injury, Meng QT*, 2022
  • Mitochondrial DNA Release Contributes to Intestinal Ischemia/Reperfusion Injury, Meng QT*, 2022
  • BNP facilitates NMB-encoded histaminergic itch via NPRC-NMBR crosstalk, Meng QT*, 2021
  • Mechanisms of Cancer Inhibition by Local Anesthetics, Meng QT*, 2021
  • The Risk of Neuraxial Anesthesia-Related Hypotension in COVID-19 Parturients Undergoing Cesarean Delivery: A Multicenter, Retrospective, Propensity Score Matched Cohort Study, Meng QT*, 2021
  • Dynamic functional connectivity associated with post-traumatic stress symptoms in COVID-19 survivors, Meng QT*, 2021
  • Gastrointestinal Symptoms Associated with Unfavorable Prognosis of COVID-19 Patients: A Retrospective Study, Meng QT*, 2020
  • Mechanism and Management of Fentanyl-Induced Cough, Meng QT*, 2020
  • The impact of type 2 diabetes and its management on the prognosis of patients with severe COVID-19, Meng QT*, 2020
  • Aggravated intestinal ischemia‑reperfusion injury is associated with activated mitochondrial autophagy in a mouse model of diabetes, Meng QT*, 2020
  • Ischemic postconditioning attenuates acute kidney injury following intestinal ischemia-reperfusion through Nrf2-regulated autophagy, anti-oxidation, and anti-inflammation in mice, Meng QT*, 2020
  • Ischemic Postconditioning Alleviates Intestinal Ischemia-Reperfusion Injury by Enhancing Autophagy and Suppressing Oxidative Stress through the Akt/GSK-3β/Nrf2 Pathway in Mice, Meng QT*, 2020
  • Role of adiponectin in diabetes myocardial ischemia-reperfusion injury and ischemic postconditioning, Meng QT*, 2020
  • Avoiding health worker infection and containing the coronavirus disease 2019 pandemic: Perspectives from the frontline in Wuhan, Meng QT*, 2020
  • Safety and efficacy of different anesthetic regimens for parturients with COVID-19 undergoing Cesarean delivery: a case series of 17 patients, Meng QT*, 2020
  • Chest computed tomography images of early coronavirus disease (COVID-19), Meng QT*, 2020
Mods Mechanism Research Prevention Perioperative Organ Protection Anesthesia Surgery Treatment

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.